Read + Share
Yang J, Liu C, Zuo Z, Cao F, et al. Neoadjuvant chemoradiotherapy plus sequential tislelizumab followed by surgery
for esophageal carcinoma (CRISEC study): A single-arm, bicentric, phase 2 trial. Radiother Oncol 2025;206:110797.
PMID: 39978682
|
 |
|
